Open AccessDelayed hypercoagulable state in COVID ‐19 adolescent patient: a case report
Author(s) -
Desdiani Desdiani,
Yulianti Nita,
Basuki Anindita
Publication year - 2021
Publication title -
respirology case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.304
H-Index - 9
ISSN - 2051-3380
DOI - 10.1002/rcr2.793
Subject(s) - medicine , covid-19 , low molecular weight heparin , azithromycin , stroke (engine) , population , disease , pediatrics , heparin , infectious disease (medical specialty) , mechanical engineering , environmental health , microbiology and biotechnology , biology , engineering , antibiotics
Coronavirus disease 2019 (COVID‐19) is a systemic hyperinflammation disease which can cause severe respiratory symptoms and extrapulmonary manifestations. Hypercoagulable state in COVID‐19 adolescent patient is a rare case. We present the case of a 16‐year‐old Indonesian boy with mild COVID‐19 symptoms. Initially, the patient was treated with azithromycin, N‐acetyl cysteine, etc. After several days of the treatment, there was clinical improvement. However, on day 15, the patient experienced hypercoagulation and stroke‐like symptoms. The patient was then subjected to additional drugs, including low‐molecular weight heparin (LMWH), and peripheral neuropathy vitamin therapy. On day 20, the clinical symptoms reduced. This case demonstrates the need for further study of the association between COVID‐19 and stroke in young population and the use of anticoagulants to prevent thrombotic events.